Biopark Lab
Biopark

Together with our university partners ULB and UMONS, we are dedicated to supporting research and development activities of biotech and pharma companies by providing innovative R&D services, including pre-clinical and molecular imaging, pre-clinical research support, flow cytometry and immuno-monitoring, next generation sequencing, drug formulation, and metabolomics and proteomics research.

The specific R&D platforms are:

CMMI

IN PARTNERSHIP WITHUMONS

Is an integrated high-performance platform for preclinical biomedical imaging including, microscopy (fluorescence ,digital holography, electron and cryo-EM microscopy), Immunohistochemistry biomarker validation, in vivo imaging (PET-CT, SPECT, MRI, Optical and Photoacoustic imaging), multimodal image processing.

PCIM

IN PARTNERSHIP WITHCER GROUP

Is a flow cytometry and immuno-monitoring platform for various applications including, molecular biology, immuno-oncology, cell therapy, cell biology, infectiology, cell proliferation, MHC dextramer technology, drug discovery, multiparametric phenotyping, cell sorting etc.

BRIGHTCore

IN PARTNERSHIP WITHVUB

Is a next generation sequencing platform performing a multitude of Massive Parallel Sequencing and Array tests including whole genome and exome sequencing, gene panels and NIPT

APFP



Is an analytical platform of the Faculty of Pharmacy offering formulation development services for pharmaceuticals.

BIO-PROFILING PLATFORM

IN PARTNERSHIP WITHUMONS

Is an advanced NMR and mass spectrometry service platform involving complex biological matrices for the identification and validation of biomarkers in metabolomics and proteomics approaches.

BUC-PRE-CLINICAL PLATFORM

The pre-clinical platform offers fully equipped specific pathogen free housing facilities and preclinical development knowhow.

ULB Technology Transfer Office

Biopark Science & Education Labs
Biopark Science & Education Labs